Dealing with a new diagnosis or confusing lab numbers? Talk with people who have been there. Compare real-world patient outcomes, lab numbers, and doctor visit tips—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Gut, Labs & Supplements Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Gut, Labs & Supplements Space →
Last Updated: Nov 22, 2026· Fact-Checked Primary Federal Data
← All Conditions (3,135) / Cancer, Oncology & Supportive Care

Cancer, Oncology & Supportive Care (168 Condition Guides)

Solid tumor and hematologic oncology overviews, screening guidelines, and supportive symptom management.

Interactive MyChart Lab & Cuff Translator • Lab Bell-Curve “Normal” vs. Physiological Optimal

Why Your Portal Says “Normal” When You Still Feel Awful: Enter Your Number

Quest and LabCorp “Normal” ranges are 95% population bell curves—not physiological optimums. Select a marker and type your result below:

3-Zone Clinical Cutoff Audit • Serum Ferritin (Iron Storage)

18 ng/mL = Marked "Normal" by Lab, Yet Clinically Depleted (< 30–50 ng/mL)

Default Sample: 18 ng/mL
Zone 1 • Clinical Cutoff
< 15 ng/mL • Overt Deficiency
< 15 ng/mL (Absolute Depletion)
Zone 2 • Portal “Normal” Gray Zone
15–49 ng/mL • "Normal" Yet Depleted
15–150 ng/mL (Quest/LabCorp Bell Curve)
Zone 3 • Physiological Optimal
50–100 ng/mL • Clinical Optimal
50–100 ng/mL (Physiological Optimal)
What This Number Means in Plain English

Commercial labs only flag Ferritin below 15 ng/mL, but clinical trials confirm fatigue, restless legs, diffuse telogen hair shedding, and impaired T4-to-T3 thyroid conversion begin whenever Ferritin drops below 30–50 ng/mL.

Action Plan: Take 25–28 mg elemental Iron Bisglycinate on alternate mornings (Mon/Wed/Fri) with Vitamin C to bypass the 24-hour hepcidin block, then re-test in 8–12 weeks.

⚠ Lab Assay & Cuff False-Alarm Check

Acute inflammation, viral illness, or fatty liver artificially elevates Ferritin (it is an acute-phase reactant). Always pair Ferritin with Fasting Transferrin Saturation (TSAT) and hs-CRP.

Specialty Directory

Cancer, Oncology & Supportive Care Guides (168)

Clear Filter × Page 3 of 5

Jaw Injuries and Disorders

Also called: Maxilla • Maxillary

Your jaw is a set of bones that holds your teeth. It includes: The maxilla, which is the upper part of your jaw. It holds your top teeth in place and doesn't move. It also supports the muscles involved in chewing and facial expressions. The mandible, which is the lower part of your jaw. You move it when you talk or chew. It also holds your lower teeth in place. The temporomandibular joints (TMJs), which are two joints (one on each side) that connect your mandible to your skull. Jaw problems can include: Fractures (broken bones). Dislocations, which are joint injuries that force the ends of your bones out of position.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Kaposi's sarcoma

Kaposi's sarcoma (ICD-10-CM C46.9) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Kidney Cancer

Also called: Hypernephroma • Renal cancer • Nephric

You have two kidneys. They are fist-sized organs on either side of your backbone above your waist. The tubes inside filter and clean your blood, taking out waste products and making urine. Kidney cancer forms in the lining of tiny tubes inside your kidneys. Kidney cancer becomes more likely as you age. Risk factors include smoking, having certain genetic conditions, and misusing pain medicines for a long time. You may have no symptoms at first. They may appear as the cancer grows.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Leiomyosarcoma

Leiomyosarcoma (ICD-10-CM C49.9) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Lentigo maligna melanoma (LMM)

Also called: Lentigo maligna melanoma

Lentigo maligna melanoma (LMM) (ICD-10-CM C43.9) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Leukemia - hairy cell

Also called: Hairy cell leukemia

Leukemia - hairy cell—coded clinically as C91.40 across Cancer & Oncology guidelines—combines immunohistochemistry [Leukemia - hairy cell C91.40] with structured follow-up of Complete Blood Count in Leukemia - hairy cell (C91.40: (ANC, Hemoglobin, Platelets)) (Safe hematologic reserve (C91.40)).

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Leukemia - monocytic

Also called: Monocytic leukemia

Leukemia - monocytic (ICD-10-CM C93.90) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Leydig cell tumor - benign

Also called: Fibroid • Leiomyoma • Fibrous

Leydig cell tumor - benign (ICD-10-CM D27.9) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Lip neoplasm - malignant

Also called: Neoplasia • Growth • Tumors

Lip neoplasm - malignant—coded clinically as C00.9 across Cancer & Oncology guidelines—combines tissue biopsy with in Lip neoplasm - malignant (C00.9: histopathology) with structured follow-up of Pathology / Molecular in Lip neoplasm - malignant (C00.9: Genomic Staging) (Guideline-concordant surveillance (C00.9)).

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Liposarcoma - myxoid

Liposarcoma - myxoid (ICD-10-CM C49.9) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Lung Cancer

Also called: Bronchogenic carcinoma • Miliary • Seeded

Lung cancer is cancer that forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women. There are two main types: small cell lung cancer and non-small cell lung cancer. These two types grow differently and are treated differently. Non-small cell lung cancer is the more common type. Who is more likely to develop lung cancer? Anyone can develop lung cancer, but certain factors raise your risk of getting it: Smoking. This is the most important risk factor for lung cancer.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Lymphangiosarcoma

Lymphangiosarcoma (ICD-10-CM C49.9) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Lymphoma

Also called: Non-Hodgkin lymphoma

Lymphoma is a cancer of a part of the immune system called the lymph system. There are many types of lymphoma. One type is Hodgkin disease. The rest are called non-Hodgkin lymphomas. Non-Hodgkin lymphomas begin when a type of white blood cell, called a T cell or B cell, becomes abnormal. The cell divides again and again, making more and more abnormal cells. These abnormal cells can spread to almost any other part of the body. Most of the time, doctors don't know why a person gets non-Hodgkin lymphoma. You are at increased risk if you have a weakened immune system or have certain types of infections.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Lymphomatoid granulomatosis

Lymphomatoid granulomatosis (ICD-10-CM C83.80) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Lymphomatoid papulosis

Lymphomatoid papulosis (ICD-10-CM C86.60) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Macroglobulinemia

Designated in federal medical registries as C88.00, Macroglobulinemia falls under Cancer & Oncology management, where multidisciplinary tumor-board planning in Macroglobulinemia (C88.00: (surgery) establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Male Breast Cancer

Although breast cancer is much more common in women, men can get it too. It happens most often to men between the ages of 60 and 70. Breast lumps usually aren't cancer. However, most men with breast cancer have lumps. Other breast symptoms can include: Dimpled or puckered skin A red, scaly nipple or skin Fluid discharge Risk factors for male breast cancer include exposure to radiation, a family history of breast cancer, and having high estrogen levels, which can happen with diseases like cirrhosis or Klinefelter syndrome. Treatment for male breast cancer is usually a mastectomy, which is surgery to remove the breast.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant giant cell tumor of bone

Also called: Metastasis • Metastases • Metastatic

Malignant giant cell tumor of bone (ICD-10-CM D48.9) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant glioma

Also called: Metastasis • Metastases • Metastatic

Malignant glioma (ICD-10-CM C72.9) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant melanoma of anal skin

Malignant melanoma of anal skin (ICD-10-CM C43.51) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant melanoma of lip

Malignant melanoma of lip (ICD-10-CM C43.0) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant melanoma of nose

Malignant melanoma of nose (ICD-10-CM C43.31) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant melanoma of other part of trunk

Malignant melanoma of other part of trunk (ICD-10-CM C43.59) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant melanoma of other parts of face

Designated in federal medical registries as C43.39, Malignant melanoma of other parts of face falls under Cancer & Oncology management, where tissue biopsy with in Malignant melanoma of other parts of face (C43.39: histopathology) establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant melanoma of overlapping sites of skin

Malignant melanoma of overlapping sites of skin (ICD-10-CM C43.8) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant melanoma of scalp and neck

Malignant melanoma of scalp and neck (ICD-10-CM C43.4) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant melanoma of skin

Malignant melanoma of skin (ICD-10-CM C43.9) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant mixed tumor

Also called: Metastasis • Metastases • Metastatic

Malignant mixed tumor (ICD-10-CM C44.99) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant neoplasm of anterior wall of bladder

Malignant neoplasm of anterior wall of bladder (ICD-10-CM C67.3) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant neoplasm of appendix

Malignant neoplasm of appendix (ICD-10-CM C18.1) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant neoplasm of ascending colon

Malignant neoplasm of ascending colon (ICD-10-CM C18.2) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant neoplasm of cecum

Malignant neoplasm of cecum (ICD-10-CM C18.0) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant neoplasm of colon

Malignant neoplasm of colon (ICD-10-CM C18.9) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant neoplasm of descending colon

Malignant neoplasm of descending colon (ICD-10-CM C18.6) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant neoplasm of hepatic flexure

Malignant neoplasm of hepatic flexure (ICD-10-CM C18.3) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits
Connected Clinical Ecosystem • Medications, Supplements & Specialists

Go From Diagnosis to Treatment: Connected Flagship Guides

Prescription Medications (/meds)

FDA DailyMed & NADAC Cash Price Guides

Decode tablet imprints, IR vs. ER stomach side effects, Rule-of-6 dose response curves, and $3–$9 generic cash prices.

Dietary Supplements (/supplements)

NIH ODS & Elemental Label Math Guides

Separate human RCT outcomes from social media hype—with elemental vs. compound weight decoders and serum 25(OH)D targets.

Verified Specialists (/doctors)

GreatDoc™ Score & Zero-Wall Insurance Check

Compare U.S. specialists by real CMS Medicare Part B procedure volume, verified Google patient reviews, and accepted PPO/Medicare plans.

Primary-Source Clinical SummaryUpdated Nov 22, 2026 · 0% Sponsored Ads

Which diagnostic lab ranges and guidelines govern Cancer, Oncology & Supportive Care (168 on dotMD.com?

dotMD.com maps Cancer, Oncology & Supportive Care (168 against ADA, ACC/AHA, USPSTF, and Endocrine Society diagnostic criteria, contrasting broad 95% portal reference intervals with optimal clinical targets. Standard portals often delay preventive action by 12 to 36 months, whereas structured 3-zone lab tracking surfaces borderline shifts early with 0% ad clutter.

Condition Care PillarAuthoritative SourceKey Quantitative BenchmarkPatient Benefit
Diagnostic Lab CutoffsADA / ACC / Endocrine3-zone optimal vs. portal rangeFlags 12–36 mo early
First-Line EvidencePubMed Phase 3 TrialsARR, NNT & 5-year risk math315 conditions covered
Medication Cash CostsCMS NADAC Survey$1–$5/mo generic benchmarks8x–40x retail savings
Doctor Visit PrepdotMD Lab Reader3–6 tailored MD questions100% free & private

How should patients prepare lab numbers and questions for a Cancer, Oncology & Supportive Care (168 visit?

dotMD.com recommends bringing 3 baseline lab panels (6 to 12 months apart), current medication and supplement doses in milligrams, and 3 targeted physician questions. Auditing treatment options by Absolute Risk Reduction (ARR) and Number Needed to Treat (NNT) clarifies real 5-year benefit in under 5 mins.

Explore Verified Federal Clinical Guides & Monographs

Explore Full Library →
Founding Household Charter Waiting List • $0 Due Today 1 Membership Covers Up to 4 Family Members ($99/Yr vs. $19.95/Mo Regular)

Stop Paying Retail Markups on What You Just Read About. Buy Directly at the Federal Wholesale Receipts on Our Screen.

Join the dotMD Wholesale Health Club™ for $99/year total (up to 4 family members) and unlock: (1) Unlimited $5-deductible 24/7 online doctor visits, (2) Unlimited generic prescriptions at Cost + 10% + $3.95 fill via Mark Cuban’s Cost Plus Drugs model, and (3) 50,000+ lab-verified supplements at Wholesale Cost + 10% + $3.95 fill.

Lock In $99/Yr Household Rate ($0 Today) No credit card required today • 100% Year-1 Savings Guarantee